QUANTUM STUDY OF THE ACTIVE SUBSTANCE DIENOGEST USED IN THE TREATMENT OF ENDOMETRIOSIS
Karina García-Aguilar*, Leticia Nández Pérez, Jesús Alberto Marcial Green, Erick Pedraza-Gress and Manuel González-Pérez
ABSTRACT
Endometriosis is a pathology that has a prevalence in women of approximately 7 million. It is a disease of idiopathic origin, so it is a mystery for some health professionals to know how to give adequate treatment. Sometimes women are affected in their daily lives by the excessive pain it causes, among other symptoms. In specialty consultations, women are medicated with the active ingredient Dienogest (DGT) to control the progress of endometriosis. The problem arises when women who have taken this active ingredient, at some point in their lives, developed more conditions than those intended to alleviate or reduce with DGT. In the DGT fact sheet,
several possible secondary conditions are presented, which encourages the following documentary and analytical research to demonstrate that this drug consumption leads to conditions beyond those established. The main objective of this research will allow demonstrating through quantum analysis how DGT molecules interact with the nitrogenous bases of DNA and RNA. We will conclude if this interaction modifies any of the unions between the five nitrogenous bases, Adenine, Guanine, Cytosine, Thymine, and Uracil, in the case of RNA.
Keywords: Dienogest, Quantum Analysis, Endometriosis, Hyperchem, Theoretical Analysis, DNA, RNA, ETC.
[Download Article]
[Download Certifiate]